Showing all 12 results
-
All Rheumatology
$900.00Skyrizi (risankizumab) is a medication used to treat adults with Plaque Psoriasis and Psoriatic Arthritis.
-
Ammonaps
$1,135.00Ammonaps (sodium phenylbutyrate) is a prescription medication that is used for the treatment of urea cycle disorders. By reducing the levels of nitrogen in the blood and promoting the excretion of excess nitrogen,
Ammonaps can improve cognitive function and liver function in patients with these conditions. 250 tablets of 500 mg
-
Jyseleca (filgotinib)
$1,592.12 – $1,601.54Jyseleca (filgotinib) is a medication used in adults to treat moderate to severe rheumatoid arthritis.
-
Sale!
Multiple Sclerosis (MS)
$87,487.00Lyvispah (baclofen) oral granules is a prescription medicine that is used to treat spasticity resulting from multiple sclerosis (MS).
-
Olumiant (baricitinib)
$1,306.70 – $4,455.46Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis.
On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
-
Rinvoq (upadacitinib)
$1,784.35Rinvoq (upadacitinib) is a medication used to treat adults with active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and ankylosing spondylitis.
-
Stelara (ustekinumab)
$17,705.43 – $35,140.12Stelara (ustekinumab) is a medication used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease, or ulcerative colitis.
-
Taltz (ixekizumab)
$3,109.60 – $4,638.40Taltz (ixekizumab) is a medication used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
-
Tremfya (guselkumab)
$3,510.00Tremfya (guselkumab) is a medication used for the treatment of adult patients with moderate-to-severe plaque psoriasis and active psoriatic arthritis.
100 mg/ml guselkumab
-
Truxima (rituximab)
$801.46 – $1,910.88Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis.
-
Tymlos (abaloparatide)
$2,990.00Tymlos (abaloparatide) is a medication used for the treatment of postmenopausal women with osteoporosis at high risk for fracture.
30 doses of 80 mcg (2000 mcg/mL)
-
Xeljanz (tofacitinib)
$1,135.16Xeljanz (tofacitinib) is a medication used for the treatment of severely active rheumatoid arthritis or active psoriatic arthritis, in patients who have had an inadequate response or intolerance to methotrexate. It is also used for moderately to severely active ulcerative colitis.
56 tablets of 5 mg
